Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07328412 · ClinicalTrials.gov registry record · NA

Aromatherapy to Address Psychological Distress in Emergency Department Patients.

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT07328412: Completed NA study, sponsored by Brigham and Women's Hospital.

NCT07328412 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07328412, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The goal of this clinical trial is to understand the feasibility and acceptability of a brief aromatherapy session for reducing stress, anxiety, and improving patient satisfaction among emergency department patients. The main question the study aims to answer is: Is the intervention acceptable and feasible? Participants in the intervention group will receive a lavender-scented tube and smell it for about 5 minutes. Participants in the control group will receive an unscented tube and follow the same instructions.

Primary Outcome

Acceptability will be assessed via the Acceptability of Intervention Measure (AIM). AIM is a 4-item Likert agreeability scale ranging from 1 (Completely disagree) to 5 (Completely agree). A mean score is calculated, resulting in a continuous score with higher scores indicating greater intervention acceptability.

Interventions

  • OTHER Lavender Aromatherapy
  • OTHER Unscented Aromatherapy

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-02-02
Est. Completion 2026-04-13
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT07328412 record still lists

NCT07328412 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Lavender Aromatherapy is the first listed.

NCT07328412 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07328412 about?

NCT07328412 is a clinical study titled "Aromatherapy to Address Psychological Distress in Emergency Department Patients.". The goal of this clinical trial is to understand the feasibility and acceptability of a brief aromatherapy session for reducing stress, anxiety, and improving patient satisfaction among emergency department patients. The main question the study aims to answer is: Is the intervention acceptable and f...

What is the current status of trial NCT07328412?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-02. Estimated completion is 2026-04-13.

What interventions are being tested in trial NCT07328412?

The interventions under investigation include: Lavender Aromatherapy (OTHER), Unscented Aromatherapy (OTHER).

Who is sponsoring clinical trial NCT07328412?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07328412's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07328412, the US trial registry maintained by the National Library of Medicine. NCT07328412 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.